• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质反应差异驱动肿瘤细胞进化和前列腺癌进展。

Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.

机构信息

Department of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Independent Researcher, New York, NY, USA.

出版信息

Nat Ecol Evol. 2020 Jun;4(6):870-884. doi: 10.1038/s41559-020-1157-y. Epub 2020 May 11.

DOI:10.1038/s41559-020-1157-y
PMID:32393869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11000594/
Abstract

Prostate cancer (PCa) progression is a complex eco-evolutionary process driven by the feedback between evolving tumour cell phenotypes and microenvironmentally driven selection. To better understand this relationship, we used a multiscale mathematical model that integrates data from biology and pathology on the microenvironmental regulation of PCa cell behaviour. Our data indicate that the interactions between tumour cells and their environment shape the evolutionary dynamics of PCa cells and explain overall tumour aggressiveness. A key environmental determinant of this aggressiveness is the stromal ecology, which can be either inhibitory, highly reactive (supportive) or non-reactive (neutral). Our results show that stromal ecology correlates directly with tumour growth but inversely modulates tumour evolution. This suggests that aggressive, environmentally independent PCa may be a result of poor stromal ecology, supporting the concept that purely tumour epithelium-centric metrics of aggressiveness may be incomplete and that incorporating markers of stromal ecology would improve prognosis.

摘要

前列腺癌(PCa)的进展是一个复杂的生态进化过程,由不断进化的肿瘤细胞表型与受微环境驱动的选择之间的反馈所驱动。为了更好地理解这种关系,我们使用了一种多尺度数学模型,该模型整合了生物学和病理学的数据,以研究微环境对 PCa 细胞行为的调节。我们的数据表明,肿瘤细胞与其环境之间的相互作用塑造了 PCa 细胞的进化动态,并解释了肿瘤的整体侵袭性。这种侵袭性的一个关键环境决定因素是基质生态学,它可以是抑制性的、高度反应性的(支持性的)或非反应性的(中性的)。我们的结果表明,基质生态学与肿瘤生长直接相关,但反过来又调节肿瘤的进化。这表明,侵袭性的、环境独立的 PCa 可能是由于基质生态不佳造成的,这支持了这样一种概念,即仅仅基于肿瘤上皮细胞的侵袭性指标可能是不完整的,而纳入基质生态学标志物将改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/4efa120c0ecc/nihms-1967220-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/6fda597d8412/nihms-1967220-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/61e2d45bdc6f/nihms-1967220-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/65297b659153/nihms-1967220-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/5204fbc8d0b7/nihms-1967220-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/6d8cab8f60da/nihms-1967220-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/2aaf8e21db5f/nihms-1967220-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/738ddd031f8e/nihms-1967220-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/4f8157931c22/nihms-1967220-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/d3ec907b83db/nihms-1967220-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/cc6c875109a5/nihms-1967220-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/4efa120c0ecc/nihms-1967220-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/6fda597d8412/nihms-1967220-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/61e2d45bdc6f/nihms-1967220-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/65297b659153/nihms-1967220-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/5204fbc8d0b7/nihms-1967220-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/6d8cab8f60da/nihms-1967220-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/2aaf8e21db5f/nihms-1967220-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/738ddd031f8e/nihms-1967220-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/4f8157931c22/nihms-1967220-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/d3ec907b83db/nihms-1967220-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/cc6c875109a5/nihms-1967220-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce00/11000594/4efa120c0ecc/nihms-1967220-f0006.jpg

相似文献

1
Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression.基质反应差异驱动肿瘤细胞进化和前列腺癌进展。
Nat Ecol Evol. 2020 Jun;4(6):870-884. doi: 10.1038/s41559-020-1157-y. Epub 2020 May 11.
2
Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.探究前列腺癌肿瘤-基质相互作用:来自进化博弈论的临床与生物学见解。
Br J Cancer. 2012 Jan 3;106(1):174-81. doi: 10.1038/bjc.2011.517. Epub 2011 Dec 1.
3
Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures.利用高通量微组织培养技术研究 2D 和 3D 共培养中前列腺癌细胞行为和药物反应的差异。
BMC Cancer. 2018 May 24;18(1):592. doi: 10.1186/s12885-018-4473-8.
4
Asporin is a stromally expressed marker associated with prostate cancer progression.阿朴脂蛋白是一种与前列腺癌进展相关的基质表达标志物。
Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.
5
Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.成骨基质细胞在前列腺癌的肿瘤基质 3D 模型中上调致瘤标志物。
Mol Cancer. 2013 Sep 30;12(1):112. doi: 10.1186/1476-4598-12-112.
6
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.YAP1 在将正常成纤维细胞转化为促进前列腺癌进展的癌相关成纤维细胞中发挥关键作用。
J Exp Clin Cancer Res. 2020 Feb 17;39(1):36. doi: 10.1186/s13046-020-1542-z.
7
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.唑来膦酸通过抑制M2巨噬细胞极化和前列腺癌相关成纤维细胞来损害基质反应性。
Oncotarget. 2017 Jan 3;8(1):118-132. doi: 10.18632/oncotarget.9497.
8
A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer.肿瘤细胞与基质细胞之间的乳酸穿梭系统与前列腺癌的不良预后相关。
BMC Cancer. 2014 May 21;14:352. doi: 10.1186/1471-2407-14-352.
9
Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.抑制 Nox4 依赖性 ROS 信号减弱前列腺成纤维细胞激活并阻断基质介导的促肿瘤发生相互作用。
Int J Cancer. 2018 Jul 15;143(2):383-395. doi: 10.1002/ijc.31316. Epub 2018 Mar 1.
10
Stromal-epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells.前列腺癌中的基质-上皮相互作用:基质细胞中 PAGE4 的过表达抑制上皮细胞的侵袭能力。
J Cell Biochem. 2020 Nov;121(11):4406-4418. doi: 10.1002/jcb.29664. Epub 2020 Jan 31.

引用本文的文献

1
Systems biology successes and areas for opportunity in prostate cancer.系统生物学在前列腺癌中的成功案例与机遇领域
Endocr Relat Cancer. 2025 Aug 20;32(8). doi: 10.1530/ERC-25-0067. Print 2025 Aug 1.
2
TIAM1 drives prostatic branching phenotype and is a potential therapeutic target for benign prostatic hyperplasia.TIAM1驱动前列腺分支表型,是良性前列腺增生的一个潜在治疗靶点。
JCI Insight. 2025 May 20;10(12). doi: 10.1172/jci.insight.188062. eCollection 2025 Jun 23.
3
Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota.

本文引用的文献

1
Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer.成纤维细胞和阿来替尼改变了非小细胞肺癌的进化博弈。
Nat Ecol Evol. 2019 Mar;3(3):450-456. doi: 10.1038/s41559-018-0768-z. Epub 2019 Feb 18.
2
Integrating Models to Quantify Environment-Mediated Drug Resistance.整合模型以量化环境介导的耐药性。
Cancer Res. 2017 Oct 1;77(19):5409-5418. doi: 10.1158/0008-5472.CAN-17-0835. Epub 2017 Jul 28.
3
Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance.
前列腺癌微环境:免疫细胞、血管系统、基质细胞和微生物群的多维调控。
Mol Cancer. 2024 Oct 12;23(1):229. doi: 10.1186/s12943-024-02137-1.
4
Modeling tumors as complex ecosystems.将肿瘤建模为复杂生态系统。
iScience. 2024 Aug 10;27(9):110699. doi: 10.1016/j.isci.2024.110699. eCollection 2024 Sep 20.
5
Phenotypic and spatial heterogeneity of CD8 tumour infiltrating lymphocytes.CD8 肿瘤浸润淋巴细胞的表型和空间异质性。
Mol Cancer. 2024 Sep 9;23(1):193. doi: 10.1186/s12943-024-02104-w.
6
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [Ga]Ga-/[F]F-PSMA-11/-1007, [Ga]Ga-FAPI-46 and 2-[F]FDG PET/CT: a pilot study.在[Ga]Ga-/[F]F-PSMA-11/-1007、[Ga]Ga-FAPI-46 和 2-[F]FDG PET/CT 上检测晚期转移性去势抵抗性前列腺癌患者的肿瘤异质性:一项初步研究。
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):342-353. doi: 10.1007/s00259-024-06891-8. Epub 2024 Aug 29.
7
Dissecting the Spatially Restricted Effects of Microenvironment-Mediated Resistance on Targeted Therapy Responses.剖析微环境介导的耐药性对靶向治疗反应的空间限制效应。
Cancers (Basel). 2024 Jun 29;16(13):2405. doi: 10.3390/cancers16132405.
8
Modeling tumors as species-rich ecological communities.将肿瘤模拟为物种丰富的生态群落。
bioRxiv. 2024 Apr 26:2024.04.22.590504. doi: 10.1101/2024.04.22.590504.
9
Enhanced prostatic Esr1 luminal epithelial cells in the absence of SRD5A2.缺乏 SRD5A2 时增强的前列腺 ESR1 腔上皮细胞。
J Pathol. 2024 Jul;263(3):300-314. doi: 10.1002/path.6283. Epub 2024 Apr 12.
10
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease.骨生态系统促进多发性骨髓瘤复发和异质性耐药疾病的演变。
Nat Commun. 2024 Mar 19;15(1):2458. doi: 10.1038/s41467-024-46594-0.
前列腺基质的细胞成分:前列腺癌进展和治疗耐药的关键贡献者。
Cold Spring Harb Perspect Med. 2018 Aug 1;8(8):a030510. doi: 10.1101/cshperspect.a030510.
4
Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3).前列腺促纤维增生性癌的组织学特征(反应性间质3级癌)
Hum Pathol. 2017 May;63:202-211. doi: 10.1016/j.humpath.2017.02.019. Epub 2017 Mar 15.
5
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.前列腺腺癌的组织学分级可进一步优化:对来自金丝雀回顾性队列的1275例患者中个体结构模式的相对预后强度分析
Am J Surg Pathol. 2016 Nov;40(11):1439-1456. doi: 10.1097/PAS.0000000000000736.
6
Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life.肿瘤学分会前列腺癌EDGE特别工作组:健康相关生活质量结局指标的系统评价
Rehabil Oncol. 2016 Jan;34(1):27-35.
7
An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer.骨转移前列腺癌骨微环境的综合计算模型。
Cancer Res. 2014 May 1;74(9):2391-401. doi: 10.1158/0008-5472.CAN-13-2652.
8
Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.肿瘤相关反应性基质中CD34(+)成纤维细胞的募集:反应性微血管假说
Am J Pathol. 2014 Jun;184(6):1860-70. doi: 10.1016/j.ajpath.2014.02.021. Epub 2014 Apr 5.
9
Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.衰老成纤维细胞在黑色素瘤起始和进展中的作用:一种综合理论、实验和临床方法。
Cancer Res. 2013 Dec 1;73(23):6874-85. doi: 10.1158/0008-5472.CAN-13-1720. Epub 2013 Sep 30.
10
A hybrid model of tumor-stromal interactions in breast cancer.乳腺癌中肿瘤-基质相互作用的混合模型。
Bull Math Biol. 2013 Aug;75(8):1304-50. doi: 10.1007/s11538-012-9787-0. Epub 2013 Jan 5.